Book Review. Should Pharmaceutical Prices be Regulated? The Strengths and Weaknesses of the British Pharmaceutical Price Regulation Scheme, IEA Health and Welfare Unit, London, 1997, 133 pages, £12.00, ISBN 0‐255 36430‐X, ISSN 1362‐9565 [Book Review]

Health Care Analysis 6 (2):168-169 (1998)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1002/(sici)1099-1042(199806)6:2<168::aid-hca4271>3.0.co;2-p

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,497

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Book Reviews : Abraham J 1995: Science, politics and the pharmaceutical industry; controversy and bias in drug regulation. London: UCL Press . 308pp. £12.95 . ISBN 1 85728 200 0. [REVIEW]C. Agathangelou - 1996 - Nursing Ethics 3 (2):181-182.
Brightening Up: The Effect of the Physician Payment Sunshine Act on Existing Regulation of Pharmaceutical Marketing.Igor Gorlach & Genevieve Pham-Kanter - 2013 - Journal of Law, Medicine and Ethics 41 (1):315-322.
The ethics of the pharmaceutical industry and the need for a dual market system.Anna Kreiner - 1995 - Journal of Medical Humanities 16 (1):55-68.
Ethics, pricing and the pharmaceutical industry.Richard A. Spinello - 1992 - Journal of Business Ethics 11 (8):617 - 626.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Book Review. Health Care Systems: Cost Containment versus Quality by Eleanor G. Feldbaum and Miriam Hughesman, 1997, Pearson Professional, London, 213 pages, £450.00, US$710, ISBN 185 334 8198. [REVIEW]Udo Schüklenk - 1998 - Health Care Analysis 6 (2):168-168.
How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism.Wendy Lipworth, Kathleen Montgomery & Miles Little - 2013 - Journal of Bioethical Inquiry 10 (3):355-367.
Exposing Nursing Students To the Marketing Methods of Pharmaceutical Companies.Murat Civaner, Ozlem Sarikaya, Sevim Ulupinar Alici & Gulcin Bozkurt - 2008 - Nursing Ethics 15 (3):396-410.
Pharmaceutical advertisements: How they deceive patients. [REVIEW]Ashish Chandra & Gary A. Holt - 1999 - Journal of Business Ethics 18 (4):359 - 366.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
The Pharmaceutical Benefits Scheme (PBS): Is It Equitable?Tracey Phelan - 2000 - Chisholm Health Ethics Bulletin 5 (4):10.
The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals. [REVIEW]John Abraham - 2008 - Medicine, Health Care and Philosophy 11 (4):415-426.
The Pharmaceutical Benefits Scheme and Some Difficult Decisions.Tracey Phelan - 2002 - Chisholm Health Ethics Bulletin 7 (3):4.

Analytics

Added to PP
2014-01-21

Downloads
15 (#953,911)

6 months
1 (#1,478,830)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references